{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:17Z","timestamp":1792785017236,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21DA039462"],"award-info":[{"award-number":["R21DA039462"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eleusis Therapeutics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psilocybin has been shown to be a powerful, long-lasting antidepressant in human clinical trials and in rodent models. Although rodents have commonly been used to model psychiatric disorders,\n                    <jats:italic>Drosophila<\/jats:italic>\n                    have neurotransmitter systems similar to mammals and many comparable brain structures involved in similar behaviors. The forced swim test (FST), which has been used extensively to evaluate compounds for antidepressant efficacy, has recently been adapted for\n                    <jats:italic>Drosophila<\/jats:italic>\n                    . The fly FST has potential to be a cost-effective, high-throughput assay for evaluating potential antidepressants. For this study we pharmacologically validated the fly FST using methamphetamine, DL-\u03b1-methyltyrosine, and the antidepressant citalopram. While methamphetamine and DL-\u03b1-methyltyrosine altered overall locomotor activity in the\n                    <jats:italic>Drosophila<\/jats:italic>\n                    Activity Monitor System (DAMS), they had no significant impact on measures of immobility in the FST. Conversely, chronic citalopram decreased measures of immobility in the FST in both sexes without increasing DAMS activity. We used the validated FST to evaluate the antidepressant-like effects of high (3.5\u00a0mM) and low (0.03\u00a0mM) doses of psilocybin. Both doses of psilocybin significantly reduced measures of immobility in male flies, but not females. 0.03\u00a0mM had an effect size comparable to chronic citalopram, and 3.5\u00a0mM had an effect size approximately twice that of chronic citalopram.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-14165-2","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T11:03:07Z","timestamp":1655290987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies"],"prefix":"10.1038","volume":"12","author":[{"given":"M.","family":"Hibicke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. D.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"14165_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1242\/dmm.026120","volume":"9","author":"B Ellenbroek","year":"2016","unstructured":"Ellenbroek, B. & Youn, J. Rodent models in neuroscience research: Is it a rat race?. Dis. Model. Mech. 9, 1079\u20131087 (2016).","journal-title":"Dis. Model. Mech."},{"key":"14165_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1326-8-35","volume":"8","author":"K Pr\u00fc\u00dfing","year":"2013","unstructured":"Pr\u00fc\u00dfing, K., Voigt, A. & Schulz, J. B. Drosophila melanogaster as a model organism for Alzheimer\u2019s disease. Mol. Neurodegener. 8, 35 (2013).","journal-title":"Mol. Neurodegener."},{"key":"14165_CR3","doi-asserted-by":"publisher","unstructured":"O\u2019Kane, C. J. Drosophila as a model organism for the study of neuropsychiatric disorders. in Molecular and Functional Models in Neuropsychiatry. 37\u201360. https:\/\/doi.org\/10.1007\/7854_2010_110 (Springer, 2011).","DOI":"10.1007\/7854_2010_110"},{"key":"14165_CR4","doi-asserted-by":"publisher","first-page":"R700","DOI":"10.1016\/j.cub.2005.08.024","volume":"15","author":"C Margulies","year":"2005","unstructured":"Margulies, C., Tully, T. & Dubnau, J. Deconstructing memory in Drosophila. Curr. Biol. 15, R700\u2013R713 (2005).","journal-title":"Curr. Biol."},{"key":"14165_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cub.2016.02.031","volume":"26","author":"F Mohammad","year":"2016","unstructured":"Mohammad, F. et al. Ancient anxiety pathways influence Drosophila defense behaviors. Curr. Biol. 26, 981\u2013986 (2016).","journal-title":"Curr. Biol."},{"key":"14165_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0960-9822(00)00336-5","volume":"10","author":"RJ Bainton","year":"2000","unstructured":"Bainton, R. J. et al. Dopamine modulates acute responses to cocaine, nicotine and ethanol in Drosophila. Curr. Biol. 10, 187\u2013194 (2000).","journal-title":"Curr. Biol."},{"key":"14165_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt, R. D., Le Pichon, M. & Jalfre, M. Depression: A new animal model sensitive to antidepressant treatments. Nature 266, 730\u2013732 (1977).","journal-title":"Nature"},{"key":"14165_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nprot.2012.044","volume":"7","author":"DA Slattery","year":"2012","unstructured":"Slattery, D. A. & Cryan, J. F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat. Protoc. 7, 1009\u20131014 (2012).","journal-title":"Nat. Protoc."},{"key":"14165_CR9","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1111\/bph.12710","volume":"171","author":"N Kokras","year":"2014","unstructured":"Kokras, N. & Dalla, C. Sex differences in animal models of psychiatric disorders. Br. J. Pharmacol. 171, 4595\u20134619 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"14165_CR10","volume-title":"Development and Evaluation of an Adolescent Chronic Restraint Stress (ACRS) Protocol to Model Adult Depression in Female Rats","author":"M Hibicke","year":"2017","unstructured":"Hibicke, M. Development and Evaluation of an Adolescent Chronic Restraint Stress (ACRS) Protocol to Model Adult Depression in Female Rats (Mercer University, 2017)."},{"key":"14165_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1037\/pha0000119","volume":"25","author":"M Hibicke","year":"2017","unstructured":"Hibicke, M., Graham, M. A. & Hayslett, R. L. Adolescent chronic restraint stress (aCRS) elicits robust depressive-like behavior in freely cycling, adult female rats without increasing anxiety-like behaviors. Exp. Clin. Psychopharmacol. 25, 74\u201383 (2017).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"14165_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1166\/jpsp.2015.1064","volume":"2","author":"P Kandi","year":"2015","unstructured":"Kandi, P., Hibicke, M. & Hayslett, R. L. Acute cytisine and diarylpropionitrile independently and additively reduce depressive-like behavior in female ovariectomized rats. J. Pharmaceut. Sci. Pharmacol. 2, 250\u2013258 (2015).","journal-title":"J. Pharmaceut. Sci. Pharmacol."},{"key":"14165_CR13","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00493","author":"M Hibicke","year":"2020","unstructured":"Hibicke, M., Landry, A. N., Kramer, H. M., Talman, Z. K. & Nichols, C. D. Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression. ACS Chem. Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.9b00493 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"14165_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1742-7843.2009.00516.x","volume":"106","author":"C Dalla","year":"2010","unstructured":"Dalla, C., Pitychoutis, P. M., Kokras, N. & Papadopoulou-Daifoti, Z. Sex differences in animal models of depression and antidepressant response. Basic Clin. Pharmacol. Toxicol. 106, 226\u2013233 (2010).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"14165_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11055-016-0284-z","volume":"46","author":"NV Kudryashov","year":"2016","unstructured":"Kudryashov, N. V., Kalinina, T. S. & Voronina, T. A. Effects of unpredictable chronic mild stress on the effects of antidepressants in the forced swimming test. Neurosci. Behav. Phys. 46, 601\u2013605 (2016).","journal-title":"Neurosci. Behav. Phys."},{"key":"14165_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/10253890.2015.1017465","volume":"18","author":"WS Neckameyer","year":"2015","unstructured":"Neckameyer, W. S. & Nieto-Romero, A. R. Response to stress in Drosophila is mediated by gender, age and stress paradigm. Stress 18, 254\u2013266 (2015).","journal-title":"Stress"},{"key":"14165_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/978-1-4939-6371-3_19","volume":"1478","author":"WS Neckameyer","year":"2016","unstructured":"Neckameyer, W. S. & Bhatt, P. Protocols to study behavior in Drosophila. Methods Mol. Biol. 1478, 303\u2013320 (2016).","journal-title":"Methods Mol. Biol."},{"key":"14165_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbr.2018.05.016","volume":"351","author":"SM Araujo","year":"2018","unstructured":"Araujo, S. M. et al. Chronic unpredictable mild stress-induced depressive-like behavior and dysregulation of brain levels of biogenic amines in Drosophila melanogaster. Behav. Brain Res. 351, 104\u2013113 (2018).","journal-title":"Behav. Brain Res."},{"key":"14165_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-61169-x","volume":"10","author":"DF Jim\u00e9nez-Garrido","year":"2020","unstructured":"Jim\u00e9nez-Garrido, D. F. et al. Effects of ayahuasca on mental health and quality of life in na\u00efve users: A longitudinal and cross-sectional study combination. Sci. Rep. 10, 1\u201312 (2020).","journal-title":"Sci. Rep."},{"key":"14165_CR20","doi-asserted-by":"publisher","unstructured":"Palhano-Fontes, F. et al. A randomized placebo-controlled trial on the antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression. bioRxiv. 103531. https:\/\/doi.org\/10.1101\/103531 (2017).","DOI":"10.1101\/103531"},{"key":"14165_CR21","doi-asserted-by":"publisher","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","volume":"7","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris, R. L. et al. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Sci. Rep. 7, 13187 (2017).","journal-title":"Sci. Rep."},{"key":"14165_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths, R. R. et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J. Psychopharmacol. 30, 1181\u20131197 (2016).","journal-title":"J. Psychopharmacol."},{"key":"14165_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075426","volume":"8","author":"F Nau","year":"2013","unstructured":"Nau, F., Yu, B., Martin, D. & Nichols, C. D. Serotonin 5-HT2A receptor activation blocks TNF-\u03b1 mediated inflammation in vivo. PLoS ONE 8, e75426 (2013).","journal-title":"PLoS ONE"},{"key":"14165_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116790","volume":"236","author":"TW Flanagan","year":"2019","unstructured":"Flanagan, T. W. et al. 5-HT2 receptor activation alleviates airway inflammation and structural remodeling in a chronic mouse asthma model. Life Sci. 236, 116790 (2019).","journal-title":"Life Sci."},{"key":"14165_CR25","doi-asserted-by":"publisher","first-page":"13444","DOI":"10.1038\/s41598-019-49987-0","volume":"9","author":"TW Flanagan","year":"2019","unstructured":"Flanagan, T. W. et al. Activation of 5-HT2 receptors reduces inflammation in vascular tissue and cholesterol levels in high-fat diet-fed apolipoprotein E knockout mice. Sci. Rep. 9, 13444 (2019).","journal-title":"Sci. Rep."},{"key":"14165_CR26","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly, C. et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 23, 3170\u20133182 (2018).","journal-title":"Cell Rep."},{"key":"14165_CR27","volume-title":"Effects of Methamphetamine and Lysergic Acid Diethylamide on Drosophila Behavior\u2014ProQuest","author":"KJ Sherman","year":"2016","unstructured":"Sherman, K. J. Effects of Methamphetamine and Lysergic Acid Diethylamide on Drosophila Behavior\u2014ProQuest (Louisiana State University Health Sciences Center, 2016)."},{"key":"14165_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.pbb.2005.06.008","volume":"81","author":"RG Pendleton","year":"2005","unstructured":"Pendleton, R. G. et al. A developmental role for catecholamines in Drosophila behavior. Pharmacol. Biochem. Behav. 81, 849\u2013853 (2005).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"14165_CR29","doi-asserted-by":"publisher","first-page":"19459","DOI":"10.1074\/jbc.273.31.19459","volume":"273","author":"EL Barker","year":"1998","unstructured":"Barker, E. L. et al. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis an aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J. Biol. Chem. 273, 19459\u201319468 (1998).","journal-title":"J. Biol. Chem."},{"key":"14165_CR30","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.neuroscience.2008.10.055","volume":"158","author":"O Johnson","year":"2009","unstructured":"Johnson, O., Becnel, J. & Nichols, C. D. Serotonin 5-HT2 and 5-HT1A-like receptors differentially modulate aggressive behaviors in Drosophila melanogaster. Neuroscience 158, 1292\u20131300 (2009).","journal-title":"Neuroscience"},{"key":"14165_CR31","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1523\/JNEUROSCI.21-20-08188.2001","volume":"21","author":"N Froger","year":"2001","unstructured":"Froger, N. et al. 5-Hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J. Neurosci. 21, 8188\u20138197 (2001).","journal-title":"J. Neurosci."},{"key":"14165_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/sj.bjp.0706859","volume":"149","author":"M-B Assi\u00e9","year":"2006","unstructured":"Assi\u00e9, M.-B., Lomenech, H., Ravailhe, V., Faucillon, V. & Newman-Tancredi, A. Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: A microdialysis study in the rat. Br. J. Pharmacol. 149, 170\u2013178 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"14165_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0361-9230(01)00623-2","volume":"56","author":"JA Gray","year":"2001","unstructured":"Gray, J. A. & Roth, B. L. Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists. Brain Res. Bull. 56, 441\u2013451 (2001).","journal-title":"Brain Res. Bull."},{"key":"14165_CR34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41386-019-0405-9","volume":"44","author":"TL Bale","year":"2019","unstructured":"Bale, T. L. et al. The critical importance of basic animal research for neuropsychiatric disorders. Neuropsychopharmacology 44, 1349\u20131353 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"14165_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2005.05.027","volume":"47","author":"Q Yuan","year":"2005","unstructured":"Yuan, Q., Lin, F., Zheng, X. & Sehgal, A. Serotonin modulates circadian entrainment in Drosophila. Neuron 47, 115\u2013127 (2005).","journal-title":"Neuron"},{"key":"14165_CR36","first-page":"1220","volume":"291","author":"GJ Rivi\u00e8re","year":"1999","unstructured":"Rivi\u00e8re, G. J., Byrnes, K. A., Gentry, W. B. & Owens, S. M. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat. J. Pharmacol. Exp. Ther. 291, 1220\u20131226 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"14165_CR37","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.12688\/f1000research.4263.2","volume":"3","author":"J Colomb","year":"2015","unstructured":"Colomb, J. & Brembs, B. Sub-strains of Drosophila Canton-S differ markedly in their locomotor behavior. F1000Res 3, 1768 (2015).","journal-title":"F1000Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14165-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:37:44Z","timestamp":1669336664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14165-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14165"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14165-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"3 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.H. has no competing interests. C.D. Nichols is a member of the Scientific Advisory Board of Eleusis Therapeutics, and has a Sponsored Research Contract with Eleusis Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10019"}}